Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 12/2018

13.07.2018 | Clinical Investigation

Comparison of Cone-Beam Tomography and Cross-Sectional Imaging for Volumetric and Dosimetric Calculations in Resin Yttrium-90 Radioembolization

verfasst von: Marco Ertreo, Hailey Choi, David Field, Jonathan W. Lischalk, Emil Cohen, George E. Lynskey, Theresa Caridi, Donna Buckley, Keith Unger, Alexander Y. Kim

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the use of cone-beam computed tomography versus contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) in the calculation of liver volume and planned dose for yttrium-90 radioembolization.

Materials and Methods

The study retrospectively assessed 47 consecutive patients who underwent resin Y-90 radioembolization consecutively over a 2-year period at a single center. Volume calculation software was used to determine perfused lobar liver volumes from cone-beam CT (CBCT) images obtained during mapping angiography. CBCT-derived volumes were compared with perfused lobar volume derived from contrast-enhanced CT and MRI. Nominal activities as determined by the SIR-Spheres Microspheres Activity Calculator were similarly calculated and compared using both CBCT and conventionally acquired volumes.

Results

A total of 82 hepatic lobes were assessed in 47 patients. The mean percentage difference between combined CT-MRI- and CBCT-derived calculated lobar volumes was 25.3% (p = 0.994). The mean percentage difference in calculated dose between the two methods was 21.8 ± 24.6% (p = 0.42). Combined left and right lobar CT-derived dose difference was less than 10% in 22 lobes, between 10 and 25% in 20 lobes, between 25 and 50% in 13 lobes and greater than 50% in 5 lobes. Combined left and right lobar MRI-derived dose difference was less than 10% in 11 lobes, between 10 and 25% in 7 lobes, between 25 and 50% in 2 lobes and greater than 50% in 1 lobe.

Conclusions

Although volume measurements derived from CT/MRI did not differ significantly from those derived from CBCT, variability between the two methods led to large and unexpected differences in calculated dose.
Literatur
2.
Zurück zum Zitat Sangro B, Gil-Alzugaray B, Rodriguez J, Sola I, Martinez-Cuesta A, Viudez A, et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer. 2008;112:1538–46.CrossRef Sangro B, Gil-Alzugaray B, Rodriguez J, Sola I, Martinez-Cuesta A, Viudez A, et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer. 2008;112:1538–46.CrossRef
3.
Zurück zum Zitat Braat MNGJA, van Erpecum KJ, Zonnenberg BA, van den Bosch MAJ, Lam MGEH. Radioembolization-induced liver disease. Eur J Gastroenterol Hepatol. 2017;29:144–52.CrossRef Braat MNGJA, van Erpecum KJ, Zonnenberg BA, van den Bosch MAJ, Lam MGEH. Radioembolization-induced liver disease. Eur J Gastroenterol Hepatol. 2017;29:144–52.CrossRef
4.
Zurück zum Zitat Gil-Alzugaray B, Chopitea A, Iñarrairaegui M, Bilbao JI, Rodriguez-Fraile M, Rodriguez J, et al. Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology. 2013;57:1078–87.CrossRef Gil-Alzugaray B, Chopitea A, Iñarrairaegui M, Bilbao JI, Rodriguez-Fraile M, Rodriguez J, et al. Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology. 2013;57:1078–87.CrossRef
5.
Zurück zum Zitat Kao YH, Hock Tan AE, Burgmans MC, Irani FG, Khoo LS, Gong Lo RH, et al. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. J Nucl Med. 2012;53:559–66.CrossRef Kao YH, Hock Tan AE, Burgmans MC, Irani FG, Khoo LS, Gong Lo RH, et al. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. J Nucl Med. 2012;53:559–66.CrossRef
6.
Zurück zum Zitat Orth RC, Wallace MJ, Kuo MD. C-Arm cone-beam CT: general principles and technical considerations for use in interventional radiology. J Vasc Interv Radiol. 2008;19:814–20.CrossRef Orth RC, Wallace MJ, Kuo MD. C-Arm cone-beam CT: general principles and technical considerations for use in interventional radiology. J Vasc Interv Radiol. 2008;19:814–20.CrossRef
7.
Zurück zum Zitat Louie JD, Kothary N, Kuo WT, Hwang GL, Hofmann LV, Goris ML, et al. Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol SIR. 2009;20:606–13.CrossRef Louie JD, Kothary N, Kuo WT, Hwang GL, Hofmann LV, Goris ML, et al. Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol SIR. 2009;20:606–13.CrossRef
8.
Zurück zum Zitat van den Hoven AF, Prince JF, de Keizer B, Vonken EJPA, Bruijnen RCG, Verkooijen HM, et al. Use of C-Arm cone beam CT during hepatic radioembolization: protocol optimization for extrahepatic shunting and parenchymal enhancement. Cardiovasc Interv Radiol. 2016;39:64–73.CrossRef van den Hoven AF, Prince JF, de Keizer B, Vonken EJPA, Bruijnen RCG, Verkooijen HM, et al. Use of C-Arm cone beam CT during hepatic radioembolization: protocol optimization for extrahepatic shunting and parenchymal enhancement. Cardiovasc Interv Radiol. 2016;39:64–73.CrossRef
9.
Zurück zum Zitat Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys. 2007;68:13–23.CrossRef Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys. 2007;68:13–23.CrossRef
10.
Zurück zum Zitat Michels NA. Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg. 1966;112:337–47.CrossRef Michels NA. Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg. 1966;112:337–47.CrossRef
11.
Zurück zum Zitat van den Hoven AF, van Leeuwen MS, Lam MGEH, van den Bosch MAAJ. Hepatic arterial configuration in relation to the segmental anatomy of the liver; observations on MDCT and DSA relevant to radioembolization treatment. Cardiovasc Interv Radiol. 2014;38:100–11.CrossRef van den Hoven AF, van Leeuwen MS, Lam MGEH, van den Bosch MAAJ. Hepatic arterial configuration in relation to the segmental anatomy of the liver; observations on MDCT and DSA relevant to radioembolization treatment. Cardiovasc Interv Radiol. 2014;38:100–11.CrossRef
12.
Zurück zum Zitat Okuda K, Moriyama M, Yasumoto M, Jinnouchi S, Shimokawa Y. Roentgenologic demonstration of spontaneous reversal of portal blood flow in cirrhosis and primary carcinoma of the liver. Am J Roentgenol. 1973;119:419–28.CrossRef Okuda K, Moriyama M, Yasumoto M, Jinnouchi S, Shimokawa Y. Roentgenologic demonstration of spontaneous reversal of portal blood flow in cirrhosis and primary carcinoma of the liver. Am J Roentgenol. 1973;119:419–28.CrossRef
13.
Zurück zum Zitat Yu J-S, Rofsky N. Magnetic resonance imaging of arterioportal shunts in the liver. Top Magn Reson Imaging. 2002;13:165–76.CrossRef Yu J-S, Rofsky N. Magnetic resonance imaging of arterioportal shunts in the liver. Top Magn Reson Imaging. 2002;13:165–76.CrossRef
14.
Zurück zum Zitat Choi BI, Lee KH, Han JK, Lee JM. Hepatic arterioportal shunts: dynamic CT and MR features. Korean J Radiol. 2002;3:1–15.CrossRef Choi BI, Lee KH, Han JK, Lee JM. Hepatic arterioportal shunts: dynamic CT and MR features. Korean J Radiol. 2002;3:1–15.CrossRef
15.
Zurück zum Zitat Van Den Hoven AF, Prince JF, De Keizer B. Use of C-Arm cone beam CT during hepatic radioembolization: protocol optimization for extrahepatic shunting and parenchymal enhancement. Cardiovasc Interv Radiol. 2016;39:64–73.CrossRef Van Den Hoven AF, Prince JF, De Keizer B. Use of C-Arm cone beam CT during hepatic radioembolization: protocol optimization for extrahepatic shunting and parenchymal enhancement. Cardiovasc Interv Radiol. 2016;39:64–73.CrossRef
16.
Zurück zum Zitat Miyayama S, Yamashiro M, Hashimoto M, Hashimoto N, Ikuno M, Okumura K, et al. Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam ct guidance technology during transcatheter arterial chemoembolization. J Vasc Interv Radiol. 2013;24:501–8.CrossRef Miyayama S, Yamashiro M, Hashimoto M, Hashimoto N, Ikuno M, Okumura K, et al. Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam ct guidance technology during transcatheter arterial chemoembolization. J Vasc Interv Radiol. 2013;24:501–8.CrossRef
17.
Zurück zum Zitat Kaufmann S, Horger T, Oelker A, Beck S, Schulze M, Nikolaou K, et al. Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: impact on tumor and liver parenchymal vascularisation. Eur J Radiol. 2015;84:2548–54.CrossRef Kaufmann S, Horger T, Oelker A, Beck S, Schulze M, Nikolaou K, et al. Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: impact on tumor and liver parenchymal vascularisation. Eur J Radiol. 2015;84:2548–54.CrossRef
18.
Zurück zum Zitat Pung L, Ahmad M, Mueller K, Rosenberg J, Stave C, Hwang GL, et al. The role of cone-beam ct in transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis. J Vasc Interv Radiol. 2016;28:334–41.CrossRef Pung L, Ahmad M, Mueller K, Rosenberg J, Stave C, Hwang GL, et al. The role of cone-beam ct in transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis. J Vasc Interv Radiol. 2016;28:334–41.CrossRef
19.
Zurück zum Zitat Kothary N, Abdelmaksoud MHK, Tognolini A, Fahrig R, Rosenberg J, Hovsepian DM, et al. Imaging guidance with C-Arm CT: prospective evaluation of its impact on patient radiation exposure during transhepatic arterial chemoembolization. J Vasc Interv Radiol. 2011;22:1535–43.CrossRef Kothary N, Abdelmaksoud MHK, Tognolini A, Fahrig R, Rosenberg J, Hovsepian DM, et al. Imaging guidance with C-Arm CT: prospective evaluation of its impact on patient radiation exposure during transhepatic arterial chemoembolization. J Vasc Interv Radiol. 2011;22:1535–43.CrossRef
20.
Zurück zum Zitat Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, et al. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med. 2012;53:255–63.CrossRef Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, et al. Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med. 2012;53:255–63.CrossRef
21.
Zurück zum Zitat Kallini JR, Gabr A, Salem R, Lewandowski RJ. Transarterial radioembolization with yttrium-90 for the treatment of hepatocellular carcinoma. Adv Ther. 2016;33:699–714.CrossRef Kallini JR, Gabr A, Salem R, Lewandowski RJ. Transarterial radioembolization with yttrium-90 for the treatment of hepatocellular carcinoma. Adv Ther. 2016;33:699–714.CrossRef
22.
Zurück zum Zitat Srinivas SM, Natarajan N, Kuroiwa J, Gallagher S, Nasr E, Shah SN, et al. Determination of radiation absorbed dose to primary liver tumors and normal liver tissue using post-radioembolization 90Y PET. Front Oncol. 2014;4:255.CrossRef Srinivas SM, Natarajan N, Kuroiwa J, Gallagher S, Nasr E, Shah SN, et al. Determination of radiation absorbed dose to primary liver tumors and normal liver tissue using post-radioembolization 90Y PET. Front Oncol. 2014;4:255.CrossRef
23.
Zurück zum Zitat Fowler KJ, Maughan NM, Laforest R, Saad NE, Sharma A, Olsen J, et al. PET/MRI of Hepatic 90Y microsphere deposition determines individual tumor response. Cardiovasc Interv Radiol. 2016;39:855–64.CrossRef Fowler KJ, Maughan NM, Laforest R, Saad NE, Sharma A, Olsen J, et al. PET/MRI of Hepatic 90Y microsphere deposition determines individual tumor response. Cardiovasc Interv Radiol. 2016;39:855–64.CrossRef
Metadaten
Titel
Comparison of Cone-Beam Tomography and Cross-Sectional Imaging for Volumetric and Dosimetric Calculations in Resin Yttrium-90 Radioembolization
verfasst von
Marco Ertreo
Hailey Choi
David Field
Jonathan W. Lischalk
Emil Cohen
George E. Lynskey
Theresa Caridi
Donna Buckley
Keith Unger
Alexander Y. Kim
Publikationsdatum
13.07.2018
Verlag
Springer US
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 12/2018
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-018-2030-0

Weitere Artikel der Ausgabe 12/2018

CardioVascular and Interventional Radiology 12/2018 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.